Literature DB >> 9453379

Vitamin A deficiency and nocturnal vision in teenagers with cystic fibrosis.

F Huet1, D Semama, C Maingueneau, A Charavel, J L Nivelon.   

Abstract

UNLABELLED: The aim of this study was to document plasma retinol status and nocturnal vision in ten eutrophic adolescents with cystic fibrosis (CF) receiving daily retinol supplementation. Plasma retinol, alpha and beta carotenes and retinol binding protein were measured in ten clinically stable CF patients (mean age: 14.3 years; Shwachman score: 80-100). Nocturnal vision evaluation was performed with a Beyne optometer. Plasma retinol (mean 0.42 +/- 0.16 mg/l), alpha carotene and beta carotene levels were below the lower limit of normal in all but one patient. Five out of ten patients with normal standard opthalmological examination presented a poor (n = 3 patients) or a pathological (n = 2) dark adaptation test. These two patients showed a dramatic increase in nocturnal vision after 1 year of adapted retinol supplementation.
CONCLUSION: Low vitamin A levels occur frequently in clinically stable, eutrophic and retinol supplemented CF adolescents. Since vitamin A deficiency is associated with poor nocturnal vision and since this pattern can be reversed by adapted retinol supplementation, we recommend monitoring plasma vitamin A levels in CF patients and evaluation of dark adaptation in retinol deficient patients.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9453379     DOI: 10.1007/s004310050749

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  8 in total

Review 1.  The role of vitamins in cystic fibrosis.

Authors:  S B Carr; J McBratney
Journal:  J R Soc Med       Date:  2000       Impact factor: 5.344

2.  Why bother to take vitamins?

Authors:  Alison Morton
Journal:  J R Soc Med       Date:  2011-07       Impact factor: 5.344

3.  Role of electroretinography in the assessment of retinal function as an indicator of vitamin A status.

Authors:  I Tsinopoulos; S Nousia-Arvanitakis; A Galli-Tsinopoulou; N Roubies; K Tentzidou; M Xefteri; N Stangos
Journal:  Doc Ophthalmol       Date:  2000-11       Impact factor: 2.379

4.  Retinol binding protein status in relation to ocular surface changes in patients with cystic fibrosis treated with daily vitamin A supplements.

Authors:  Malgorzata Mrugacz; Jolanta Tobolczyk; Alina Minarowska
Journal:  Eur J Pediatr       Date:  2004-11-20       Impact factor: 3.183

5.  Antioxidants in cystic fibrosis. Conclusions from the CF antioxidant workshop, Bethesda, Maryland, November 11-12, 2003.

Authors:  André M Cantin; Terry B White; Carroll E Cross; Henry Jay Forman; Ronald J Sokol; Drucy Borowitz
Journal:  Free Radic Biol Med       Date:  2006-09-29       Impact factor: 7.376

6.  Relationship Between Fat-Soluble Vitamin Supplementation and Blood Concentrations in Adolescent and Adult Patients With Cystic Fibrosis.

Authors:  Oranan Siwamogsatham; Wei Dong; Jose N Binongo; Ritam Chowdhury; Jessica A Alvarez; Shawna J Feinman; Jessica Enders; Vin Tangpricha
Journal:  Nutr Clin Pract       Date:  2014-04-17       Impact factor: 3.080

7.  ERGs in children with pancreatic enzyme insufficient and pancreatic enzyme sufficient cystic fibrosis.

Authors:  Andrew Whatham; Catherine Suttle; Caron Blumenthal; Jane Allen; Kevin Gaskin
Journal:  Doc Ophthalmol       Date:  2009-03-03       Impact factor: 2.379

8.  Oral Supplementation with a Special Additive of Retinyl Palmitate and Alpha Tocopherol Reduces Growth Retardation in Young Pancreatic Duct Ligated Pigs Used as a Model for Children Suffering from Exocrine Pancreatic Insufficiency.

Authors:  Anne Mößeler; Marion Schmicke; Martin Höltershinken; Martin Beyerbach; Josef Kamphues
Journal:  Int J Mol Sci       Date:  2016-09-28       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.